USADA announced today that Christian Hesch, an athlete in the sport of Track & Field, has accepted a two-year suspension for committing an anti-doping rule violation.
Hesch voluntarily admitted having used erythropoietin (EPO) which is prohibited under the USADA Protocol for Olympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (Code) and the World Anti-Doping Agency Prohibited List.
Hesch’s two-year period of ineligibility began on September 26, 2012, the date he admitted his use of EPO to USADA. Under the Code Mr. Hesch was eligible for a six-month reduction of the period of ineligibility based on his voluntary admission to USADA regarding his doping activities. As a result, he will be required to serve the remaining 18-months of his sanction. Hesch has also been disqualified from all competitive results achieved on and subsequent to August 27, 2010, the date he admitted to first using EPO, including forfeiture of any medals, points, and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.